Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-03-18 Sale | 2024-03-19 7:05 pm | Tarsus Pharmaceuticals Inc. | TARS | Wahl Bryan General Counsel | 4,436 | $30.6 | $135,742 | 72,276 (Direct) | View |
| 2023-11-30 Sale | 2023-12-01 4:55 pm | Tarsus Pharmaceuticals Inc. | TARS | Wahl Bryan General Counsel | 8,356 | $16.31 | $136,286 | 31,966 (Direct) | View |
| 2023-03-21 Sale | 2023-03-23 7:52 pm | Tarsus Pharmaceuticals Inc. | TARS | Wahl Bryan General Counsel | 1,078 | $12.55 | $13,532 | 16,402 (Direct) | View |
| 2023-03-17 Sale | 2023-03-21 7:14 pm | Tarsus Pharmaceuticals Inc. | TARS | Wahl Bryan General Counsel | 696 | $12.94 | $9,004 | 17,480 (Direct) | View |
| 2023-03-16 Sale | 2023-03-17 6:21 pm | Tarsus Pharmaceuticals Inc. | TARS | Wahl Bryan General Counsel | 337 | $13.43 | $4,526 | 32,546 (Direct) | View |
| 2022-12-02 Sale | 2022-12-06 5:49 pm | Tarsus Pharmaceuticals Inc. | TARS | Wahl Bryan General Counsel | 1,154 | $16.9 | $19,503 | 13,723 (Direct) | View |
| 2022-11-30 Sale | 2022-12-01 7:58 pm | Tarsus Pharmaceuticals Inc. | TARS | Wahl Bryan General Counsel | 2,347 | $16.62 | $39,017 | 38,797 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-03-15 Exercise | 2024-03-19 7:05 pm | N/A N/A | Tarsus Pharmaceuticals Inc. | TARS | Wahl Bryan General Counsel | 24,076 | $0 | 72,276 (Direct) | View |
| 2024-03-07 Option Award | 2024-03-11 5:45 pm | N/A 2034-03-06 | Tarsus Pharmaceuticals Inc. | TARS | Wahl Bryan General Counsel | 71,202 | $0 | 71,202 (Direct) | View |
| 2023-11-29 Exercise | 2023-12-01 4:55 pm | N/A N/A | Tarsus Pharmaceuticals Inc. | TARS | Wahl Bryan General Counsel | 23,920 | $0 | 31,966 (Direct) | View |
| 2023-03-15 Exercise | 2023-03-17 6:21 pm | N/A N/A | Tarsus Pharmaceuticals Inc. | TARS | Wahl Bryan General Counsel | 4,790 | $0 | 32,546 (Direct) | View |
| 2023-03-08 Option Award | 2023-03-10 7:29 pm | N/A 2033-03-08 | Tarsus Pharmaceuticals Inc. | TARS | Wahl Bryan General Counsel | 71,795 | $0 | 71,795 (Direct) | View |
| 2022-11-29 Exercise | 2022-12-01 7:58 pm | N/A N/A | Tarsus Pharmaceuticals Inc. | TARS | Wahl Bryan General Counsel | 10,251 | $0 | 38,797 (Direct) | View |
| 2022-03-09 Option Award | 2022-03-11 4:15 pm | N/A 2032-03-08 | Tarsus Pharmaceuticals Inc. | TARS | Wahl Bryan General Counsel | 118,643 | $0 | 118,643 (Direct) | View |
| 2021-02-02 Option Award | 2021-02-02 7:57 pm | N/A 2031-02-02 | Tarsus Pharmaceuticals Inc. | TARS | Wahl Bryan General Counsel | 89,368 | $0 | 89,368 (Direct) | View |
Ownership | 2021-01-21 1:24 pm | N/A N/A | Tarsus Pharmaceuticals Inc. | TARS | Wahl Bryan General Counsel | 0 | $0 | 5,000 (Direct) | View |